IBDEI14V ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18929,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,18929,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,18930,0)
 ;;=C50.919^^94^916^121
 ;;^UTILITY(U,$J,358.3,18930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18930,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,18930,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,18930,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,18931,0)
 ;;=C62.90^^94^916^159
 ;;^UTILITY(U,$J,358.3,18931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18931,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,18931,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,18931,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,18932,0)
 ;;=D03.9^^94^916^161
 ;;^UTILITY(U,$J,358.3,18932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18932,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,18932,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,18932,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,18933,0)
 ;;=C45.0^^94^916^162
 ;;^UTILITY(U,$J,358.3,18933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18933,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,18933,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,18933,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,18934,0)
 ;;=C90.01^^94^916^164
 ;;^UTILITY(U,$J,358.3,18934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18934,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,18934,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,18934,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,18935,0)
 ;;=C90.00^^94^916^165
 ;;^UTILITY(U,$J,358.3,18935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18935,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,18935,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,18935,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,18936,0)
 ;;=C94.6^^94^916^166
 ;;^UTILITY(U,$J,358.3,18936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18936,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,18936,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,18936,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,18937,0)
 ;;=D61.82^^94^916^167
 ;;^UTILITY(U,$J,358.3,18937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18937,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,18937,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,18937,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,18938,0)
 ;;=D47.9^^94^916^168
 ;;^UTILITY(U,$J,358.3,18938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18938,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,18938,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,18938,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,18939,0)
 ;;=D53.9^^94^916^172
 ;;^UTILITY(U,$J,358.3,18939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18939,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18939,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,18939,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,18940,0)
 ;;=D47.4^^94^916^173
 ;;^UTILITY(U,$J,358.3,18940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18940,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,18940,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,18940,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,18941,0)
 ;;=D59.1^^94^916^27
 ;;^UTILITY(U,$J,358.3,18941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18941,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,18941,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,18941,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,18942,0)
 ;;=D51.3^^94^916^187
 ;;^UTILITY(U,$J,358.3,18942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18942,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,18942,1,4,0)
 ;;=4^D51.3
